Cardiff Lexington Corp (CDIX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3753 HOWARD HUGHES PARKWAY LAS VEGAS, NV 89169 |
| State of Incorp. | FL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,188 | 867 | 227 | 596 | 279 | 101 | |||
| Cash and cash equivalent | 1,188 | 867 | 227 | 596 | 279 | 101 | |||
| Receivables | 15,934 | 13,305 | 6,605 | 4,949 | 16 | 118 | |||
| Inventory, net of allowances, customer advances and progress billings | 3 | ||||||||
| Inventory | 3 | ||||||||
| Other undisclosed current assets | 90 | 5 | 5 | 5 | 10 | ||||
| Total current assets: | 17,213 | 14,177 | 6,837 | 5,550 | 296 | 232 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 407 | 289 | 219 | 284 | 53 | 382 | |||
| Inventory, real estate | 540 | 540 | 540 | 540 | 603 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 21 | 35 | 55 | 259 | 212 | 273 | |||
| Long-term investments and receivables | 5 | ||||||||
| Due from related parties | ✕ | ✕ | ✕ | 5 | |||||
| Intangible asset, including goodwill, after accumulated amortization | 5,667 | 5,667 | 5,667 | 4,484 | 3,754 | 3,754 | |||
| Goodwill | 5,667 | 5,667 | 5,667 | 4,484 | 3,500 | 3,500 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 254 | 254 | |||||||
| Other undisclosed noncurrent assets | 78 | 38 | 36 | 39 | 14 | 656 | |||
| Total noncurrent assets: | 6,713 | 6,569 | 6,517 | 5,610 | 4,634 | 5,065 | |||
| TOTAL ASSETS: | 23,926 | 20,746 | 13,353 | 11,160 | 4,930 | 5,297 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,380 | 2,047 | 2,039 | 1,393 | 617 | 878 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 449 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 57 | 28 | 59 | ||
| Accounts payable | 684 | 721 | 342 | 171 | 120 | 237 | |||
| Accrued liabilities | 437 | 638 | 452 | 40 | 159 | 197 | |||
| Other undisclosed accounts payable and accrued liabilities | 258 | 688 | 1,245 | 675 | 311 | 386 | |||
| Deferred revenue | 354 | 297 | |||||||
| Debt | 3,622 | 87 | 2,493 | 2,536 | 948 | 370 | |||
| Derivative instruments and hedges, liabilities | 2,904 | 3,102 | |||||||
| Disposal group, including discontinued operation | 238 | 238 | 471 | 2,692 | 2,342 | ||||
| Due to related parties | ✕ | ✕ | ✕ | 0 | 2,361 | 1,743 | |||
| Other undisclosed current liabilities | 10,647 | 11,488 | 5,442 | 3,714 | 3,528 | 1,580 | |||
| Total current liabilities: | 15,887 | 13,861 | 9,974 | 8,114 | 13,403 | 10,313 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 252 | 145 | 140 | 265 | |||||
| Long-term debt, excluding current maturities | 252 | 145 | 140 | 143 | |||||
| Liabilities, other than long-term debt | 186 | 119 | 85 | ||||||
| Operating lease, liability | 186 | 119 | 85 | 122 | |||||
| Other undisclosed noncurrent liabilities | (122) | 400 | 895 | ||||||
| Total noncurrent liabilities: | 438 | 264 | 225 | 265 | 400 | 895 | |||
| Total liabilities: | 16,324 | 14,124 | 10,198 | 8,379 | 13,802 | 11,208 | |||
| Temporary equity, including noncontrolling interest | |||||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 2,685 | 731 | (1,470) | 2,781 | (8,872) | (5,910) | |||
| Common stock | 15 | 1,805 | 790 | 167 | 5 | 677 | |||
| Treasury stock, value | (4,968) | (2,366) | |||||||
| Additional paid in capital | 22,711 | (9,366) | (8,554) | (3,826) | 46,111 | 42,794 | |||
| Accumulated deficit | (72,949) | (68,684) | (70,855) | (66,195) | (65,583) | (61,742) | |||
| Warrants and rights outstanding | 0 | 4 | 6 | ||||||
| Other undisclosed equity, attributable to parent | 52,908 | 76,977 | 77,150 | 77,602 | 12,956 | 12,355 | |||
| Other undisclosed equity | 4,916 | 5,890 | 4,625 | 0 | |||||
| Total equity: | 7,601 | 6,622 | 3,155 | 2,781 | (8,872) | (5,910) | |||
| TOTAL LIABILITIES AND EQUITY: | 23,926 | 20,746 | 13,353 | 11,160 | 4,930 | 5,297 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 8,270 | 11,853 | 11,998 | 10,009 | 3,453 | 4,541 | ||
| Cost of revenue | (3,842) | (3,561) | (4,457) | (3,848) | (1,668) | (2,297) | ||
| Gross profit: | 4,428 | 8,293 | 7,541 | 6,160 | 1,785 | 2,244 | ||
| Operating expenses | (4,622) | (3,098) | (5,849) | (4,534) | (3,589) | (3,560) | ||
| Operating income (loss): | (194) | 5,195 | 1,692 | 1,626 | (1,804) | (1,316) | ||
| Nonoperating expense | (2,998) | (2,080) | (7,162) | (3,055) | (1,115) | (4,757) | ||
| Interest and debt expense | 79 | (440) | 1,397 | (2,983) | (144) | (489) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (3,113) | 2,675 | (4,073) | (4,412) | (3,063) | (6,562) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (79) | 440 | (1,397) | 2,983 | ||||
| Income (loss) from continuing operations before income taxes: | (3,192) | 3,115 | (5,470) | (1,429) | (3,063) | (6,562) | ||
| Other undisclosed income from continuing operations | 144 | 489 | ||||||
| Income (loss) from continuing operations: | (3,192) | 3,115 | (5,470) | (1,429) | (2,920) | (6,073) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (410) | (2,837) | (6,364) | |
| Income (loss) from discontinued operations | (111) | (87) | 41 | 1,019 | 83 | (291) | ||
| Net income (loss) attributable to parent: | (3,303) | 3,028 | (5,430) | (410) | (2,837) | (6,364) | ||
| Preferred stock dividends and other adjustments | (962) | (780) | ||||||
| Net income (loss) available to common stockholders, diluted: | (4,265) | 2,248 | (5,430) | (410) | (2,837) | (6,364) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (3,303) | 3,028 | (5,430) | (410) | (2,837) | (6,364) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (3,303) | 3,028 | (5,430) | (410) | (2,837) | (6,364) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.